John W. Bristol & Co Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Waters Corp
WAT
|
+$53M |
| 2 |
Air Products & Chemicals
APD
|
+$23.7M |
| 3 |
Comcast
CMCSA
|
+$16.1M |
| 4 |
CERN
Cerner Corp
CERN
|
+$896K |
| 5 |
American Express
AXP
|
+$656K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RHT
Red Hat Inc
RHT
|
+$24.2M |
| 2 |
Mastercard
MA
|
+$23.7M |
| 3 |
Progressive
PGR
|
+$19.9M |
| 4 |
US Bancorp
USB
|
+$19.7M |
| 5 |
Wells Fargo
WFC
|
+$19.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.17% |
| 2 | Consumer Discretionary | 14.6% |
| 3 | Healthcare | 14.28% |
| 4 | Financials | 14.16% |
| 5 | Communication Services | 11.12% |
Similar funds
John W. Bristol & Co's Q4 2018 Portfolio in Review
As of Q4 2018, John W. Bristol & Co held 99 positions worth $3.18B, down 16% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
John W. Bristol & Co withdrew a net $130M in Q4 2018, closing 13 positions and reducing 47 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $306K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, John W. Bristol & Co opened a new position in Waters Corp worth $52.6M.
- John W. Bristol & Co's largest Q4 2018 buy was Waters Corp: 278,856 shares worth $52.6M.
- John W. Bristol & Co added most to Air Products & Chemicals in Q4 2018, an estimated $23.7M increase.
- John W. Bristol & Co's biggest Q4 2018 reduction was Red Hat Inc, cutting an estimated $24.2M.
- John W. Bristol & Co fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $306K.
- John W. Bristol & Co's ten largest holdings make up 29% of its $3.18B portfolio in Q4 2018.
- John W. Bristol & Co opened 14 new positions and closed 13 in Q4 2018.
- John W. Bristol & Co's portfolio value fell 16% quarter-over-quarter to $3.18B.
Based on John W. Bristol & Co's 13F filing for Q4 2018, filed 7 Feb 2019.